Treatment of inflammatory airway disease in young standardbreds with interferon alpha

Canadian Veterinary Journal

Volumn 45, Issue 7, 2004, Pages 594-601

  Moore, Ian ^a   Horney, Barbara ^a   Day, Kendra ^a   Lofstedt, Jeanne ^a   Cribb, Alastair E ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMINOPHYLLINE; BUTORPHANOL TARTRATE; CEFTIOFUR; COTRIMAZINE; DETOMIDINE; GUAIFENESIN; OXYTETRACYCLINE; PENICILLIN G; PLACEBO; RECOMBINANT ALPHA INTERFERON; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREEDING; CONTROLLED STUDY; COUGHING; DISEASE DURATION; HORSE DISEASE; MALE; NONHUMAN; NOSE DISEASE; RANDOMIZATION; RESPIRATORY TRACT INFLAMMATION; REST; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TRACHEA MUCUS; TRAINING;

ADMINISTRATION, ORAL; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DOUBLE-BLIND METHOD; FEMALE; HORSE DISEASES; HORSES; INTERFERON TYPE I, RECOMBINANT; MALE; RESPIRATORY TRACT DISEASES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 4344564104     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Moore BR. Lower respiratory tract disease. Vet Clin North Am Equine Pract 1996;12:457-472.
2. Moore BR, Krakowka S, Robertson JT, Cummins JM. Cytologic evaluation of bronchoalveolar lavage fluid obtained from Standardbred racehorses with inflammatory airway disease. Am J Vet Res 1995;56:562-567.
3. MacKay RJ. What's new with inhalant therapies for inflammatory airway disease in horses? Compend Contin Educ Pract Vet 1999;21: 353-355.
4. Couetil LL, Rosenthal FS, DeNicola DB, Chilcoat CD. Clinical signs, evaluation of bronchoalveolar lavage fluid, and assessment of pulmonary function in horses with inflammatory respiratory disease. Am J Vet Res 2001;62:538-546.
5. Moore BR, Krakowka S, Cummins JM, Robertson JT. Changes in airway inflammatory cell populations in Standardbred racehorses after interferon-alpha administration. Vet Immunol Immunopathol 1996;49:347-358.
6. Moore BR, Krakowka S, Mcvey DS, Cummins JM, Robertson JT. Inflammatory markers in bronchoalveolar lavage fluid of Standardbred racehorses with inflammatory airway disease: response to interferon-alpha. Equine Vet J 1997;29:142-147.
7. Derksen FJ, Brown CM, Sonea I, Darien BJ, Robinson NE. Comparison of transtracheal aspirate and bronchoalveolar lavage cytology in 50 horses with chronic lung disease. Equine Vet J 1989;21:23-26.
8. Viel L. Lower airway inflammation in young performance horses. In: Robinson NE, ed. Current Therapy in Equine Medicine, 4th ed. Philadelphia: WB Saunders, 1997:426-428.
9. Mannering GJ, Deloria LB. The pharmacology and toxicology of interferons: an overview. Annu Rev Pharmacol Toxicol 1986;26: 777-781.
10. Fleischmann WR, Koren S, Fleischmann CM. Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism. Proc Soc Exp Biol Med 1992;201:200-207.
11. Moore BR. Clinical applications of interferons in large animal medicine. J Am Vet Med Assoc 1996;208:1711-1715.
12. Perron Lepage MF, Gerber V, Suter MM. A case of interstitial pneumonia associated with Pneumocystis carinii in a foal. Vet Pathol 1999;36:621-624.
13. Flaminio MJ, Rush BR, Cox JH, Moore WE. CD4+ and CD8+ T-lymphocytopenia in a filly with Pneumocystis carinii pneumonia. Aust Vet J 1998;76:399-402.
14. Ewing PJ, Cowell RL, Tyler RD, MacAllister CG, Meinkoth JH. Pneumocystis carinii pneumonia in foals. J Am Vet Med Assoc 1994;204:929-933.